SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 599.15 |
| Book Value / Share | 1.58 |
| Price / Book | n/a |
| NCAV ($M) | 370.92 |
| NCAV / Share | 0.98 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.08 |
| Return on Assets (ROA) | -0.03 |
| Return on Equity (ROE) | -0.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.32 |
| Current Ratio | 1.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,611.67 |
| Assets | 1,839.90 |
| Liabilities | 1,240.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,393,004 | 3,561,181 | 39.12 | |
| 3,262,891 | 8,965,728 | 36.39 | |
| 3,578,601 | 11,030,110 | 32.44 | |
| 10,390,756 | 33,063,861 | 31.43 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BOLT – Bolt Biotherapeutics, Inc. | BON – Bon Natural Life Limited |
| BTAI – BioXcel Therapeutics, Inc. | BYSI – BeyondSpring Inc. |
| CALC – CalciMedica, Inc. |
Financial data and stock pages provided by
Fintel.io